Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30011232HIVENSG00000116478.13protein_codingHDAC1YesNo3065Q13547
Q6IT96
TVIS30011233HIVENSG00000116478.13protein_codingHDAC1YesNo3065Q13547
Q6IT96
TVIS30023050HIVENSG00000116478.13protein_codingHDAC1YesNo3065Q13547
Q6IT96
TVIS30023051HIVENSG00000116478.13protein_codingHDAC1YesNo3065Q13547
Q6IT96
TVIS30023052HIVENSG00000116478.13protein_codingHDAC1YesNo3065Q13547
Q6IT96
TVIS30023053HIVENSG00000116478.13protein_codingHDAC1YesNo3065Q13547
Q6IT96
TVIS30023054HIVENSG00000116478.13protein_codingHDAC1YesNo3065Q13547
Q6IT96
TVIS30023055HIVENSG00000116478.13protein_codingHDAC1YesNo3065Q13547
Q6IT96
TVIS30023056HIVENSG00000116478.13protein_codingHDAC1YesNo3065Q13547
Q6IT96
TVIS30023057HIVENSG00000116478.13protein_codingHDAC1YesNo3065Q13547
Q6IT96
TCGA Plot Options
Drug Information
GeneHDAC1
DrugBank IDDB05015
Drug NameBelinostat
Target IDBE0008667
UniProt IDQ9UKV0
Regulation Typeinhibitor
PubMed IDs28090369; 32503121
CitationsHood K, Shah A: Belinostat for Relapsed or Refractory Peripheral T-Cell Lymphoma. J Adv Pract Oncol. 2016 Mar;7(2):209-218. Epub 2016 Mar 1.@@Curreli F, Ahmed S, Victor SMB, Debnath AK: Identification of Combinations of Protein Kinase C Activators and Histone Deacetylase Inhibitors That Potently Reactivate Latent HIV. Viruses. 2020 Jun 3;12(6). pii: v12060609. doi: 10.3390/v12060609.
GroupsApproved; Investigational
Direct ClassificationCinnamic acids and derivatives
SMILESONC(=O)C=CC1=CC=CC(=C1)S(=O)(=O)NC1=CC=CC=C1
Pathways
PharmGKB
ChEMBLCHEMBL408513